Stockscreener 앱 받기
2.74%
시간 외 거래:
전일 마감가:
$25.92
열려 있는:
$25.581
하루 거래량:
119.39M
Relative Volume:
3.18
시가총액:
$143.68B
수익:
$63.32B
순이익/손실:
$7.52B
주가수익비율:
19.33
EPS:
1.3043
순현금흐름:
$9.48B
1주 성능:
-3.67%
1개월 성능:
-0.47%
6개월 성능:
+0.68%
1년 성능:
+5.57%
1일 변동 폭
$24.94
$25.66
1주일 범위
$24.94
$26.49
52주 변동 폭
$23.11
$28.75
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE vs LLY, JNJ, ABBV, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
25.21 | 143.68B | 63.32B | 7.52B | 9.48B | 1.3043 |
LLY
Lilly Eli Co
|
1,098.57 | 979.64B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
228.39 | 549.78B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
216.49 | 382.49B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
113.87 | 281.24B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
147.08 | 280.64B | 54.66B | 13.58B | 16.05B | 7.0171 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-02 | 업그레이드 | Argus | Hold → Buy |
| 2026-02-25 | 개시 | RBC Capital Mkts | Underperform |
| 2026-02-20 | 개시 | Barclays | Underweight |
| 2026-02-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-02 | 재개 | Citigroup | Neutral |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer StockWeekly sector check after pneumococcal vaccine update - AD HOC NEWS
mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GSK Patent Infringement Cases - JD Supra
Appeals Court Scraps Redo Of Pfizer, Flynn Drug Fines - Law360
PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed - TradingView
Pfizer shares dip after CFO departure raises new questions about 2026 outlook - TechStock²
Pfizer CEO on leaving Europe in pursuit of the American dream: The ‘opportunities are enormous’ - New York Post
Key facts: Pfizer Reaffirms FY26; CFO Denton Exits Aug 15; Guegan Int. - TradingView
Pfizer reaffirms outlook after CFO exit (update) - MSN
Pfizer reaffirms 2026 financial guidance following CFO transition By Investing.com - Investing.com India
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook - Yahoo Finance
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook - The Motley Fool
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Pfizer Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Pfizer CFO departs for consumer goods sector - CFO Dive
Pfizer Shares Dip 1.5% as CFO Dave Denton Announces Exit - TradingView
Pfizer CFO Exit Adds Pressure - TradingView
Pfizer reaffirms 2026 financial guidance following CFO transition - Investing.com
Pfizer reaffirms outlook after CFO exit (update) (PFE:NYSE) - Seeking Alpha
Pfizer reafffirms 2026 guidance after CFO transition announcement By Investing.com - Investing.com Canada
Pfizer reafffirms 2026 guidance after CFO transition announcement - Investing.com
Pfizer Stock Drops Today As CFO Steps Down In August - Benzinga
Pfizer (PFE) Names Cecile Guegan Interim CFO As Dave Denton Prepares To Exit - Yahoo Finance
Why Accenture, Pfizer, and Kroger are moving today - Yahoo Finance
Pfizer Slides as Investors Appear to Reassess Near-Term Growth Catalysts - Quiver Quantitative
Pfizer (PFE) Shares Sink 3% Following CFO Dave Denton’s Resignation Announcement - Blockonomi
Pfizer (PFE) Shares Slide 3% Following CFO Dave Denton’s Departure Announcement - Blockonomi
Pfizer (PFE) Shares Sink After Surprise CFO Exit - TipRanks
Pfizer CFO Dave Denton to step down, interim CFO appointed - grafa.com
Pfizer Names Cecile Guegan Interim CFO Following Dave Denton’s Departure - citybiz
Pfizer CFO Dave Denton to leave company in August - Reuters
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space? - Yahoo Finance
Pfizer launches CFO search as Denton plans to depart in August - Crain's New York Business
Pfizer Announces Search for New Chief Financial Officer - Contract Pharma
Living Longer with Cancer: Redefining What It Means to Survive - Pfizer
Pfizer supporting employees with migraine through flexible work arrangements, raising awareness about condition - Benefits Canada.com
Pfizer Shares Slip Following CFO Transition Announcement - Yahoo Finance
Pfizer CFO Dave Denton to step down, leave company in August - BNN Bloomberg
Pfizer CFO Dave Denton stepping down in August 2026 - Yahoo Finance
Pfizer CFO Dave Denton to return to consumer goods roots - FirstWord Pharma
Pfizer Launches CFO Search as Denton Plans to Depart in August - Bloomberg.com
Pfizer CFO Dave Denton to step down, Cecile Guegan named interim - Investing.com
Pfizer stock falls as CFO Dave Denton to step down in August - Investing.com
Pfizer CFO Dave Denton to Step Down; Cecile Guegan Named Interim CFO - TradingView
Pfizer Chief Financial Officer Dave Denton to Leave - marketscreener.com
Pfizer Announces Chief Financial Officer Transition - Business Wire
Pfizer CFO Dave Denton to Depart; Interim CFO Named - marketscreener.com
Pfizer CFO Dave Denton to step down in August - Breakingthenews.net
Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in ObesitySlideshow (NYSE:PFE) 2026-06-17 - Seeking Alpha
Pfizer: Why I'm Still Expecting A Massive Rebound (NYSE:PFE) - Seeking Alpha
Pfizer Stock And Two AI Healthcare Plays That Look Mispriced - simplywall.st
Questions over Pfizer’s marketing claims resurface as scrutiny grows around blockbuster drug promotion - EU Reporter
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
자본화:
|
볼륨(24시간):